Patent: 9,468,643
✉ Email this page to a colleague
Summary for Patent: 9,468,643
Title: | PDE5 inhibitor compositions and methods for immunotherapy |
Abstract: | The invention features methods and compositions featuring a PDE5 inhibitor for treating or preventing immunological-mediated disease in a subject. |
Inventor(s): | Borrello; Ivan M. (Baltimore, MD), Serafini; Paolo (Miami Shores, FL), Noonan; Kimberly A. (Baltimore, MD), Bronte; Vincenzo (Abano Terme, IT) |
Assignee: | The Johns Hopkins University (Baltimore, MD) |
Application Number: | 14/281,363 |
Patent Claims: | see list of patent claims |
Details for Patent 9,468,643
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2025-01-07 |
Servier Pharmaceuticals Llc | ONCASPAR | pegaspargase | Injection | 103411 | 02/01/1994 | ⤷ Try a Trial | 2025-01-07 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2025-01-07 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2025-01-07 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |